Economic Evaluation of Vaccination Programmes
- 1 January 2002
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 20 (1) , 1-7
- https://doi.org/10.2165/00019053-200220010-00001
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Economic evaluations of hepatitis B immunization: a global review of recent studies (1994–2000)Health Economics, 2001
- Discounting for health effects in cost–benefit and cost‐effectiveness analysisHealth Economics, 2001
- Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicityJournal of Hepatology, 2001
- Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.2000
- Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 2000
- Clinical and Economic Impact of a Combination Haemophilus influenzae and Hepatitis B VaccineArchives of Pediatrics & Adolescent Medicine, 1999
- Economic evaluations applied to HB vaccination: general observationsVaccine, 1998
- Accounting for future costs in medical cost-effectiveness analysisJournal of Health Economics, 1997
- Cost Effectiveness of Alternative Hepatitis A Immunisation StrategiesPharmacoEconomics, 1995
- Discounting and health benefitsHealth Economics, 1992